{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Albuterol+HFA+MDI", "query": { "intervention": "Albuterol HFA MDI" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 47, "total_pages": 5, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Albuterol+HFA+MDI&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-24T18:47:45.079Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00809757", "title": "A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Levalbuterol", "type": "DRUG" }, { "name": "Levalbuterol UDV TID", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "48 Months", "sex": "ALL", "summary": "Up to 48 Months" }, "enrollment_count": 197, "start_date": "2008-12", "completion_date": "2013-06", "has_results": true, "last_update_posted_date": "2014-07-28", "last_synced_at": "2026-09-24T18:47:45.079Z", "location_count": 46, "location_summary": "Little Rock, Arkansas • Cypress, California • Long Beach, California + 35 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Cypress", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Redwood City", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00809757" }, { "nct_id": "NCT06139991", "title": "Study to Assess the Pharmacokinetic Bioequivalence of Budesonide and Albuterol With an Alternate Propellant Compared to Current Propellant.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Heathy Participants" ], "interventions": [ { "name": "Treatment A (BDA MDI HFO)", "type": "DRUG" }, { "name": "Treatment B (BDA MDI HFA)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 66, "start_date": "2023-11-16", "completion_date": "2024-05-04", "has_results": false, "last_update_posted_date": "2026-05-07", "last_synced_at": "2026-09-24T18:47:45.079Z", "location_count": 1, "location_summary": "Glendale, California", "locations": [ { "city": "Glendale", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06139991" }, { "nct_id": "NCT02150499", "title": "A Study of Levalbuterol Tartrate HFA Inhalation Aerosol Metered Dose Inhaler (MDI) in Pediatric Subjects", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "levalbuterol tartrate HFA inhalation aerosol", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "48 Months", "sex": "ALL", "summary": "Up to 48 Months" }, "enrollment_count": 18, "start_date": "2014-07", "completion_date": "2014-12", "has_results": true, "last_update_posted_date": "2016-04-08", "last_synced_at": "2026-09-24T18:47:45.079Z", "location_count": 17, "location_summary": "St. Petersburg, Florida • DeKalb, Illinois • Nicholasville, Kentucky + 12 more", "locations": [ { "city": "St. Petersburg", "state": "Florida" }, { "city": "DeKalb", "state": "Illinois" }, { "city": "DeKalb", "state": "Illinois" }, { "city": "Nicholasville", "state": "Kentucky" }, { "city": "Shreveport", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT02150499" }, { "nct_id": "NCT02040766", "title": "A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants Ages 4-11 Years Old With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Beclomethasone dipropionate BAI", "type": "DRUG" }, { "name": "Placebo BAI", "type": "DRUG" }, { "name": "albuterol/salbutamol 90 mcg", "type": "DRUG" }, { "name": "Beclomethasone dipropionate MDI", "type": "DRUG" }, { "name": "Placebo MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "4 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "4 Years to 11 Years" }, "enrollment_count": 628, "start_date": "2013-12", "completion_date": "2016-03", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-24T18:47:45.079Z", "location_count": 75, "location_summary": "Hoover, Alabama • Montgomery, Alabama • Phoenix, Arizona + 62 more", "locations": [ { "city": "Hoover", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Costa Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02040766" }, { "nct_id": "NCT03371459", "title": "Assessment of the Safety, Efficacy, PK, and Extrapulmonary Pharmacodynamics (PD) of Albuterol Sulfate Pressurized Inhalation Suspension (Hereafter Referred to as AS MDI) Compared to Proventil as an Active Control in Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "AS MDI", "type": "DRUG" }, { "name": "Proventil", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "18 Years to 45 Years" }, "enrollment_count": 46, "start_date": "2017-12-29", "completion_date": "2018-03-26", "has_results": true, "last_update_posted_date": "2019-07-23", "last_synced_at": "2026-09-24T18:47:45.079Z", "location_count": 5, "location_summary": "Winter Park, Florida • North Dartmouth, Massachusetts • St Louis, Missouri + 2 more", "locations": [ { "city": "Winter Park", "state": "Florida" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" }, { "city": "Raleigh", "state": "North Carolina" }, { "city": "Medford", "state": "Oregon" } ], "official_url": "https://clinicaltrials.gov/study/NCT03371459" }, { "nct_id": "NCT00818454", "title": "4 Week 2 Way Crossover Double Blind Treatment Phase With Combivent CFC Versus Albuterol Followed by a 4 Week Open Label Combivent Respimat When All Drugs Are Used for Symptom Relief as Needed in Pts With Moderate to Severe Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Combivent CFC MDI", "type": "DRUG" }, { "name": "Albuterol HFA MDI", "type": "DRUG" }, { "name": "Respimat Combivent", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 226, "start_date": "2008-12", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-09-24T18:47:45.079Z", "location_count": 41, "location_summary": "Birmingham, Alabama • Los Angeles, California • Palmdale, California + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palmdale", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00818454" }, { "nct_id": "NCT00684827", "title": "A Safety and Tolerability Study of Levalbuterol HFA Metered Dose Inhaler in Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Levalbuterol HFA MDI followed by Racemic albuterol HFA MDI", "type": "DRUG" }, { "name": "Racemic Albuterol followed by levalbuterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 32, "start_date": "2002-10", "completion_date": "2003-02", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-09-24T18:47:45.079Z", "location_count": 4, "location_summary": "Encinitas, California • Los Angeles, California • North Dartmouth, Massachusetts + 1 more", "locations": [ { "city": "Encinitas", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "North Dartmouth", "state": "Massachusetts" }, { "city": "St Louis", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT00684827" }, { "nct_id": "NCT00685425", "title": "Dose Response Study of Levalbuterol in the Prevention of Exercise Induced Bronchoconstriction Compared to Racemic Albuterol", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma", "Bronchoconstriction" ], "interventions": [ { "name": "Levalbuterol HFA MDI", "type": "DRUG" }, { "name": "Racemic Albuterol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Sumitomo Pharma America, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 62, "start_date": "2002-10", "completion_date": "2003-03", "has_results": false, "last_update_posted_date": "2012-02-22", "last_synced_at": "2026-09-24T18:47:45.079Z", "location_count": 5, "location_summary": "Los Angeles, California • Signal Hill, California • Denver, Colorado + 2 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Signal Hill", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Burke", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00685425" }, { "nct_id": "NCT02141854", "title": "Efficacy and Safety Study of FP MDPI Compared With FS MDPI in Adolescent and Adult Patients With Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FS MDPI", "type": "DRUG" }, { "name": "Fp MDPI", "type": "DRUG" }, { "name": "Placebo MDPI", "type": "DRUG" }, { "name": "Albuterol/salmeterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Teva Branded Pharmaceutical Products R&D, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 882, "start_date": "2014-06", "completion_date": "2015-09", "has_results": true, "last_update_posted_date": "2021-11-09", "last_synced_at": "2026-09-24T18:47:45.079Z", "location_count": 85, "location_summary": "Birmingham, Alabama • Little Rock, Alaska • Phoenix, Arizona + 74 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Alaska" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Encinitas", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02141854" }, { "nct_id": "NCT00096616", "title": "Combivent® CFC Metered Dose Inhaler (MDI) in Moderate to Severe Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Combivent® CFC MDI", "type": "DRUG" }, { "name": "Albuterol HFA MDI", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 113, "start_date": "2004-11", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-11-01", "last_synced_at": "2026-09-24T18:47:45.079Z", "location_count": 27, "location_summary": "Birmingham, Alabama • Lakewood, California • Palmdale, California + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Lakewood", "state": "California" }, { "city": "Palmdale", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00096616" } ] }